Hypoglycemia risk is generally low with tirzepatide monotherapy due to its glucose-dependent mechanism, but patients taking concurrent sulfonylureas or insulin require careful monitoring and possible dose adjustments of these medications
Yes, PMS can cause water retention
Zepbound Tirzepatide Injection Prefilled Syringes 2.5 mg/0.5 mL are available by prescription only and should be used as directed by a healthcare provider. They should not be used to treat type 1 diabetes or diabetic ketoacidosis. Some possible side effects of this medication may include nausea, vomiting, diarrhea, discomfort at the injection site, and decreased appetite
Establishing a consistent weekly schedule helps maintain appropriate drug concentrations
This is exactly why every MHRA-approved GLP-1 medication is either an injection or a specially engineered tablet, never a patch
What the FDA said is that sort of these bad reactions that are specifically tied to compounded medications last time I checked they kind of number in the hundreds